Richard L Schilsky

发表

Development and Validation of a Natural Language Processing Tool to Generate the CONSORT Reporting Checklist for Randomized Clinical Trials

Xiaofei Wang, Fan Wang, Richard L Schilsky, 2020, JAMA network open.

The promise of Immuno-oncology: implications for defining the value of cancer treatment

Prasun Subedi, Richard L Schilsky, James Wu, 2019, Journal of Immunotherapy for Cancer.

Highlights from the 2015 WIN Symposium: novel targets, innovative agents, and advanced technologies—a WINning strategy?

Richard L Schilsky, 2015, Ecancermedicalscience.

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

David J Sugarbaker, Richard L Schilsky, R. Schilsky, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Toward efficient trials in colorectal cancer: the ARCAD Clinical Trials Program.

Daniel J Sargent, Daniel G Haller, Richard L Schilsky, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

J Jack Lee, Eitan Rubin, Razelle Kurzrock, 2019, Nature Medicine.

Cetuximab in the treatment of colorectal cancer.

Richard L Schilsky, R. Schilsky, R. Goldberg, 2004, Clinical advances in hematology & oncology : H&O.

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

Richard L Schilsky, Larry Norton, James N Ingle, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

Bruce D Cheson, David A Mankoff, Daniel C Sullivan, 2005, Clinical Cancer Research.

Building a rapid learning health care system for oncology: the regulatory framework of CancerLinQ.

Richard L Schilsky, Peter Paul Yu, R. Schilsky, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.

Maximilian Diehn, Brooke L. Billman, Richard L Schilsky, 2018, Archives of pathology & laboratory medicine.

Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.

Richard L Schilsky, David M Dilts, Stephen L George, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancer.

Soma Das, Federico Innocenti, Michael L Maitland, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Precision cancer medicine: the future is now, only better.

Richard L Schilsky, Apostolia M Tsimberidou, R. Schilsky, 2014, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303

Yusuke Nakamura, Chen Jiang, Kouros Owzar, 2011, Clinical Cancer Research.

Cooperative group tissue banks as research resources: the cancer and leukemia group B tissue repositories.

Richard L Schilsky, Saul Suster, M. Caligiuri, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.

Barbara L. Smith, Robert Livingston, Richard L Schilsky, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists.

Richard L Schilsky, Peter B Bach, R. Schilsky, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology.

Richard L Schilsky, Michael N Neuss, Howard A Fine, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.

J Jack Lee, Razelle Kurzrock, Richard L Schilsky, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.

Adam P Dicker, Thomas J. Smith, Gary H Lyman, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.

Edward S. Kim, Richard L Schilsky, Elizabeth Garrett-Mayer, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.